NCT02735070 - Study Comparing Coristina® D to Resfenol® in the Symptomatic Treatment of Common Cold | Biotech Hunter

Enrollment

366

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions

Cold

Interventions

DRUG

Resfenol

Patients should take the study medication without breaking or chewing together with a cup containing approximately 200 ml of water. The patient should ingest the study drug after fasting for at least 30 minutes.

DRUG

Coristina d

Patients included in the study will take the drugs 4 times a day, orally. Patients should take the study medication without breaking or chewing together with a cup containing approximately 200 ml of water. The patient should ingest the study drug after fasting for at least 30 minutes.